Search

Author/Creator Mehta-Shah, N

1. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. (September 2022)

Authors:
Bagot, M; Muller, M; Kim, YH; Ortiz-Romero, PL; Zinzani, PL; Beylot-Barry, M; Dalle, S; Jacobsen, E; Combalia, A; Huen, A; Mehta-Shah, N; Khodadoust, MS; Viotti, J; Paiva, C; Porcu, P
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search